Trusted Resource for Clinical Trials, Protocols & Progress
Data flow mapping is a visual and documented representation of how personal and clinical trial data moves through various systems, vendors, and geographies. Regulatory authorities like the EMA and FDA now expect sponsors and CROs to maintain detailed flowcharts showing:
Click to read the full article.
A data breach is defined as any unauthorized access, disclosure, alteration, or loss of personal data. In clinical research, this often involves subject data collected via electronic systems such as:
Click to read the full article.
A Data Protection Impact Assessment (DPIA) is a structured process used to evaluate potential privacy risks when handling personal data in a clinical trial. Under the EU GDPR Article 35, a DPIA is required when a study:
Click to read the full article.
Data localization refers to the legal requirement to store or process data within the borders of the country where it was collected. In clinical trials, localization mandates impact trial master file (TMF) hosting, EDC servers, patient registries, and pharmacovigilance databases. Authorities across the globe have enacted data residency rules to ensure:
Click to read the full article.
The Health Insurance Portability and Accountability Act (HIPAA) is a U.S. federal law enacted in 1996 that protects individuals’ medical records and other personal health information (PHI). For U.S.-based clinical trials involving protected health information (PHI or ePHI), HIPAA compliance is non-negotiable. HIPAA applies when:
Click to read the full article.
The General Data Protection Regulation (GDPR) is the cornerstone of data privacy legislation in the European Union. Any clinical trial that processes data from EU residents, regardless of where the sponsor, CRO, or site is located, must comply with GDPR. The regulation introduces strict requirements for:
Click to read the full article.
Multi-factor authentication (MFA) adds an additional layer of login security by requiring more than just a username and password. In clinical trials, where systems like EDC, CTMS, IRT, and eTMF manage sensitive patient and protocol data, implementing MFA is critical to:
Click to read the full article.
In traditional clinical trial environments, each system (EDC, eTMF, CTMS, IRT, etc.) has its own login. This siloed access approach leads to:
Click to read the full article.
In clinical trials, staff offboarding is not just an HR matter—it is a critical compliance and data integrity concern. Failure to promptly revoke system access for departing personnel can result in:
Click to read the full article.
In GxP-regulated clinical research, access to electronic systems must be controlled and monitored to prevent data manipulation, unauthorized disclosure, and protocol violations. Traditional periodic audits or post-event log reviews are no longer sufficient.
Click to read the full article.
